Company Profile
Movano Stock Price, News & Analysis
- Ticker:
- MOVE
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
12.14 USD (-0.16%)
Close
Last updated: August 6, 2026
41.4M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, MOVE was little changed and closed at $12.14. No new same-company headline was identified in the current news window.
Company overview
Business overview
Movano was a health-technology company focused on wearable monitoring and consumer health sensors before its restructuring and decline. Its story centered on sensor-enabled health measurement.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ before restructuring, Movano sat in consumer health technology.
Business Model Characteristics
The company depended on product adoption, hardware execution, and the commercialization of wearable sensing.
Position Within the Biotechnology Landscape
Movano belongs to the historical consumer-health technology category rather than the current live public-company set.
Future catalysts
Movano’s catalysts are wearable-health adoption, FDA or product milestones, and whether the company can keep its consumer-medical platform alive. The market will care about commercial traction more than the concept.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Movano (MOVE)?
Movano (MOVE) most recently closed at 12.14 USD, a -0.16% move versus the previous session.
What is the market cap of Movano (MOVE)?
Movano currently has a market capitalization of 41.4M USD on BioPharmSignal.
What does Movano do?
Movano was a health-technology company focused on wearable monitoring and consumer health sensors before its restructuring and decline. Its story centered on sensor-enabled health measurement.
On which exchange is MOVE stock listed?
Movano (MOVE) is associated with NASDAQ, United States, Biopharma.
What is Movano?
Movano’s catalysts are wearable-health adoption, FDA or product milestones, and whether the company can keep its consumer-medical platform alive.
Which conditions is Movano targeting with Movano?
Movano’s catalysts are wearable-health adoption, FDA or product milestones, and whether the company can keep its consumer-medical platform alive.
How does Movano describe recent progress with Movano?
Movano’s catalysts are wearable-health adoption, FDA or product milestones, and whether the company can keep its consumer-medical platform alive.
What future catalysts are investors watching for Movano?
Movano’s catalysts are wearable-health adoption, FDA or product milestones, and whether the company can keep its consumer-medical platform alive. The market will care about commercial traction more than the concept.